Latest News - Research and Publications

Wednesday, March 20, 2019

Are Skin Diseases More Common Than Previously Held?

Skin diseases may be more common than previously believed, according to a new study in the Journal of the European Academy of Dermatology and Venereology that estimates the prevalence of skin diseases…

Read the full story

Tuesday, March 19, 2019

More Positive Results Seen with Endo’s Injectable Cellulite Treatment

Endo International plc’s injectable cellulite treatment collagenase clostridium histolyticum ("CCH") showed a clinically meaningful and statistically significant improvement compared t…

Read the full story

Monday, March 18, 2019

Dermira’s Investigational AD Drug Performs Well in Phase 2b Trial, Shares Skyrocket

All three doses of Dermira, Inc.’s lebrikizumab showed greater improvements in the Eczema Area and Severity Index in a new Phase 2b dose-ranging study of adults with moderate-to-severe atopic de…

Read the full story

Friday, March 15, 2019

Pilot Study: Regular Moisturization May Cut Dementia Risk

Inflamed skin in older adults may contribute to a wide range of age-related conditions including heart disease and Alzheimer’s disease, but regular moisturization may cool the inflammation and l…

Read the full story

Wednesday, March 13, 2019

Study: Port Wine Stain Laser Treatment Is Safe and Effective in Infants Without Anesthesia

Recent concerns about the repetitive use of general anesthesia in children younger than 3 have placed greater importance on the controversy surrounding the timing of port-wine stain laser treatme…

Read the full story

Thursday, March 07, 2019

New Mouse Model Validates How “Good” and “Bad” Bacteria Affect Acne

Researchers at University of California San Diego School of Medicine, Cedars-Sinai and UCLA have developed a new mouse model that closely resembles human acne by adding one new factor -- a synthetic…

Read the full story

Monday, March 04, 2019

Almirall: Positive Data for KX2-391 for AKs; ThermiGen to be Divested

Results from two Phase III studies of KX2-391, also known as KX-01 ointment,  in the treatment of actinic keratosis show positive results. The findings have been presented at the 2019 Americ…

Read the full story

Monday, March 04, 2019

Pulse Biosciences, Inc’s CellFX System Performs Well in Sebaceous Hyperplasia Study

Pulse Biosciences, Inc’s CellFX Nano-Pulse Stimulation system cleared more than 90 percent of sebaceous hyperplasia (SH) lesions in a study presented at the 2019 American Academy of Dermato…

Read the full story

Saturday, March 02, 2019

Bimekizumab Provides Long-Term Skin Clearance for Psoriasis Patients in Phase 2b Study

UCB’s bimekizumab demonstrated long-term maintenance of complete or almost complete skin disease resolution for psoriasis patients, according to results from the Phase 2b BE ABLE 2 Extension Stu…

Read the full story

Friday, March 01, 2019

Regenerative Medicine Breakthrough: Mobile Bedside Bioprinter May Heal Wounds

Researchers have created a mobile skin bioprinting system that allows bi-layered skin to be printed directly into a wound. The team demonstrated proof-of-concept of the system by printing skin dire…

Read the full story

Friday, March 01, 2019

Hyperhidrosis May Up Risk for Anxiety, Depression and ADD

Individuals with hyperhidrosis are more to have anxiety, depression and attention deficit disorder, according to new research presented at the American Academy of Dermatology’s (AAD) 2019 Annual…

Read the full story

Friday, March 01, 2019

Study: Isotretinoin Does Not Raise Depression Risk

Isotretinoin is not an independent risk factor for depression in adult acne patients, finds new research presented at the 2019 American Academy of Dermatology (AAD) Annual Meeting in Washington. &l…

Read the full story

Friday, March 01, 2019

Floodwaters and Climate Change Increase Risks for Dermatologic Disease

As more frequent and intense flooding disasters have occurred in conjunction with progressively rising temperatures, both disaster victims and relief workers have experienced significant dermatologic …

Read the full story

Monday, February 25, 2019

TARGET PharmaSolutions Launches Real-World Study to Advance the Understanding of AD and Other IMISCs

TARGET PharmaSolutions, Inc., has launched its latest large-scale observational study, TARGET-DERM (NCT03661866).  The study will deliver real-world evidence for several immune-mediated inflammat…

Read the full story

Friday, February 15, 2019

Dermatology Drugs Market to Reach $34.5 Billion by 2023

The dermatology drugs market is expected to reach $34.5 billion by 2023, a new report suggests. Research and Markets says that, among topical corticosteroids, retinoids, biologics, calcineurin in…

Read the full story
Load More